{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:24:22Z","timestamp":1778696662793,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1124\/jpet.106.110361","type":"journal-article","created":{"date-parts":[[2006,10,3]],"date-time":"2006-10-03T00:36:04Z","timestamp":1159835764000},"page":"108-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Licofelone, a Balanced Inhibitor of Cyclooxygenase and 5-Lipoxygenase, Reduces Inflammation in a Rabbit Model of Atherosclerosis"],"prefix":"10.1016","volume":"320","author":[{"given":"Cristina","family":"Vidal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almudena","family":"G\u00f3mez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"S\u00e1nchez-Gal\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Antonio","family":"G\u00f3mez-Gerique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Tu\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Egido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.106.110361_bib1","doi-asserted-by":"crossref","unstructured":"Altman R, Luciardi HL, Muntaner J, Del Rio F, Berman SG, Lopez R, Gonzalez C (2002) Efficacy assessment of meloxicam, a preferential cyclooxygenase-2 inhibitor, in acute coronary syndromes without ST-segment elevation: the nonsteroidal anti-inflammatory drugs in unstable angina treatment-2 (NUT-2) pilot study. Circulation 106: 191\u2013195.","DOI":"10.1161\/01.CIR.0000021599.56755.A1"},{"key":"10.1124\/jpet.106.110361_bib2","doi-asserted-by":"crossref","unstructured":"Anthonsen MW, Andersen S, Solhaug A, and Johansen B (2001) Atypical lambda\/iota PKC conveys 5-lipoxygenase\/leukotriene B4-mediated cross-talk between phospholipase A2s regulating NF-kappa B activation in response to tumor necrosis factor-\u03b1 and interleukin-1\u03b2. J Biol Chem 21: 35344\u201335351.","DOI":"10.1074\/jbc.M105264200"},{"key":"10.1124\/jpet.106.110361_bib3","doi-asserted-by":"crossref","unstructured":"Barnes PJ and Karin M (1997) Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066\u20131071.","DOI":"10.1056\/NEJM199704103361506"},{"key":"10.1124\/jpet.106.110361_bib4","doi-asserted-by":"crossref","unstructured":"Bias P, Buchner A, Klesser B, and Laufer S (2004) The gastrointestinal tolerability of the LOX\/COX inhibitor, licofelone, is similar to placebo and superior to naproxen therapy in healthy volunteers: results from a randomized, controlled trial. Am J Gastroenterol 99: 611\u2013618.","DOI":"10.1111\/j.1572-0241.2004.04133.x"},{"key":"10.1124\/jpet.106.110361_bib5","doi-asserted-by":"crossref","unstructured":"Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC, et al. (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR study group. N Engl J Med 343: 1520\u20131528.","DOI":"10.1056\/NEJM200011233432103"},{"key":"10.1124\/jpet.106.110361_bib6","doi-asserted-by":"crossref","unstructured":"Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, et al. (2005) Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med 352: 1092\u20131102.","DOI":"10.1056\/NEJMoa050493"},{"key":"10.1124\/jpet.106.110361_bib7","doi-asserted-by":"crossref","unstructured":"Chenevard R, Hurlimann D, Bechir M, Enseleit F, Spieker L, Hermann M, Riesen W, Gay S, Gay RE, Neidhart M, et al. (2003) Selective COX-2 inhibition improves endothelial function in coronary artery disease. Circulation 107: 405\u2013409.","DOI":"10.1161\/01.CIR.0000051361.69808.3A"},{"key":"10.1124\/jpet.106.110361_bib8","doi-asserted-by":"crossref","unstructured":"Cicero AF, Derosa G, and Gaddi A (2005) Combined lipoxygenase\/cyclo-oxygenase inhibition in the elderly: the example of licofelone. Drugs Aging 22: 393\u2013403.","DOI":"10.2165\/00002512-200522050-00004"},{"key":"10.1124\/jpet.106.110361_bib9","doi-asserted-by":"crossref","unstructured":"Friedrich EB, Tager AM, Liu E, Pettersson A, Owman C, Munn L, Luster AD, and Gerszten RE (2003) Mechanisms of leukotriene B4-triggered monocyte adhesion. Arterioscler Thromb Vasc Biol 23: 1761\u20131767.","DOI":"10.1161\/01.ATV.0000092941.77774.3C"},{"key":"10.1124\/jpet.106.110361_bib10","doi-asserted-by":"crossref","unstructured":"Fujita H, Saito F, Sawada T, Kushiro T, Yagi H, and Kanmatsuse K (1999) Lipoxygenase inhibition decreases neointimal formation following vascular injury. Atherosclerosis 147: 69\u201375.","DOI":"10.1016\/S0021-9150(99)00165-3"},{"key":"10.1124\/jpet.106.110361_bib11","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Presa MA, Bustos C, Ortego M, Tu\u00f1\u00f3n J, Renedo G, Ruiz-Ortega M, and Egido J (1997) Angiotensin-converting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 95: 1532\u20131541.","DOI":"10.1161\/01.CIR.95.6.1532"},{"key":"10.1124\/jpet.106.110361_bib12","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Presa MA, Mart\u00edn-Ventura JL, Ortego M, Gomez-Hernandez A, Tunon J, Hernandez-Vargas P, Blanco-Colio LM, Mas S, Aparicio C, Ortega L, et al. (2002) Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells. Atherosclerosis 160: 49\u201358.","DOI":"10.1016\/S0021-9150(01)00547-0"},{"key":"10.1124\/jpet.106.110361_bib13","doi-asserted-by":"crossref","unstructured":"Huang L, Zhao A, Wong F, Ayala JM, Struthers M, Ujjainwalla F, Wright SD, Springer MS, Evans J, and Cui J (2004) Leukotriene B4 strongly increases monocyte chemoattractant protein-1 in human monocytes. Arterioscler Thromb Vasc Biol 24: 1783\u20131788.","DOI":"10.1161\/01.ATV.0000140063.06341.09"},{"key":"10.1124\/jpet.106.110361_bib14","doi-asserted-by":"crossref","unstructured":"Jovanovic DV, Fernandes JC, Martel-Pelletier J, Jolicoeur FC, Reboul P, and Laufer S (2001) In vivo dual inhibition of cyclooxygenase and lipoxygenase by ML3000 reduces the progression of experimental osteoarthritis. Suppression of collagenase 1 and interleukin-1beta synthesis. Arthritis Rheum 44: 2320\u20132330.","DOI":"10.1002\/1529-0131(200110)44:10<2320::AID-ART394>3.0.CO;2-P"},{"key":"10.1124\/jpet.106.110361_bib15","doi-asserted-by":"crossref","unstructured":"Lee HY, Kim MK, Park KS, Shin EH, and Bae YS (2005) Group IB secretory phospholipase A2 stimulates leukotriene B4 production by a unique mechanism in human neutrophils. Biochem Biophys Res Commun 334: 500\u2013508.","DOI":"10.1016\/j.bbrc.2005.06.115"},{"key":"10.1124\/jpet.106.110361_bib16","doi-asserted-by":"crossref","unstructured":"Lehmann FS and Beglinger C (2005) Impact of COX-2 inhibitors in common clinical practice a gastroenterologist\u2019s perspective. Curr Top Med Chem 5: 449\u2013464.","DOI":"10.2174\/1568026054201703"},{"key":"10.1124\/jpet.106.110361_bib17","doi-asserted-by":"crossref","unstructured":"Linton MF and Fazio S (2004) Cyclooxygenase-2 and inflammation in atherosclerosis. Curr Opin Pharmacol 4: 116\u2013123.","DOI":"10.1016\/j.coph.2003.12.003"},{"key":"10.1124\/jpet.106.110361_bib18","doi-asserted-by":"crossref","unstructured":"Martel-Pelletier J, Lajeunesse D, Reboul P, and Pelletier JP (2003) Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs. Ann Rheum Dis 62: 501\u2013509.","DOI":"10.1136\/ard.62.6.501"},{"key":"10.1124\/jpet.106.110361_bib19","doi-asserted-by":"crossref","unstructured":"Martel-Pelletier J, Mineau F, Fahmi H, Laufer S, Reboul P, Boileau C, Lavigne M, and Pelletier JP (2004) Regulation of the expression of 5-lipoxygenase-activating protein\/5-lipoxygenase and the synthesis of leukotriene B4 in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids. Arthritis Rheum 50: 3925\u20133933.","DOI":"10.1002\/art.20632"},{"key":"10.1124\/jpet.106.110361_bib20","doi-asserted-by":"crossref","unstructured":"Mart\u00edn-Ventura JL, Blanco-Colio LM, Mu\u00f1oz-Garcia B, G\u00f3mez-Hernandez A, Arribas A, Ortega L, Tu\u00f1\u00f3n J, and Egido J (2004) NF-kappaB activation and Fas ligand overexpression in blood and plaques of patients with carotid atherosclerosis: potential implication in plaque instability. Stroke 35: 458\u2013463.","DOI":"10.1161\/01.STR.0000114876.51656.7A"},{"key":"10.1124\/jpet.106.110361_bib21","doi-asserted-by":"crossref","unstructured":"Moreau M, Daminet S, Martel-Pelletier J, Fernandes J, and Pelletier JP (2005) Superiority of the gastroduodenal safety profile of licofelone over rofecoxib, a COX-2 selective inhibitor, in dogs. J Vet Pharmacol Ther 28: 81\u201386.","DOI":"10.1111\/j.1365-2885.2004.00640.x"},{"key":"10.1124\/jpet.106.110361_bib22","doi-asserted-by":"crossref","unstructured":"Mukherjee D, Nissen SE, and Topol EJ (2001) Risk of cardiovascular events associated with selective COX-2 inhibitors. J Am Med Assoc 286: 954\u2013959.","DOI":"10.1001\/jama.286.8.954"},{"key":"10.1124\/jpet.106.110361_bib23","unstructured":"Nomoto K, Oguchi S, Watanabe I, Kushiro T, and Kanmatsuse K (2003) Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1. J Cardiol 42: 201\u2013206."},{"key":"10.1124\/jpet.106.110361_bib24","doi-asserted-by":"crossref","unstructured":"Pelletier JP, Boileau C, Boily M, Brunet J, Mineau F, Geng C, Reboul P, Laufer S, Lajeunesse D, and Martel-Pelletier J (2005) The protective effect of licofelone on experimental osteoarthritis is correlated with the downregulation of gene expression and protein synthesis of several major cartilage catabolic factors: MMP-13, cathepsin K and aggrecanases. Arthritis Res Ther 7: R1091\u2013R1102.","DOI":"10.1186\/ar1788"},{"key":"10.1124\/jpet.106.110361_bib25","doi-asserted-by":"crossref","unstructured":"Rotondo S, Dell Elba G, Krause-Brzosko K, Mnarini S, Martelli N, and Pecce R (2002) Licofelone, a dual lipoxygenase-cyclooxigenase inhibitor, down regulates polymorphonuclear leukocyte and platelet function. Eur J Pharmacol 453: 131\u2013139.","DOI":"10.1016\/S0014-2999(02)02385-3"},{"key":"10.1124\/jpet.106.110361_bib26","doi-asserted-by":"crossref","unstructured":"Rotondo S, Krauze-Brzosko K, Manarini S, Evangelista V, and Cerletti C (2004) Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation. Eur J Pharmacol 488: 79\u201383.","DOI":"10.1016\/j.ejphar.2004.02.006"},{"key":"10.1124\/jpet.106.110361_bib27","doi-asserted-by":"crossref","unstructured":"Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF, et al. (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib long-term arthritis safety study. J Am Med Assoc 284: 1247\u20131255.","DOI":"10.1001\/jama.284.10.1247"},{"key":"10.1124\/jpet.106.110361_bib28","doi-asserted-by":"crossref","unstructured":"Singh VP, Patil CS, and Kulkarni SK (2006) Anti-inflammatory effect of licofelone against various inflammatory challenges. Fundam Clin Pharmacol 20: 65\u201371.","DOI":"10.1111\/j.1472-8206.2005.00387.x"},{"key":"10.1124\/jpet.106.110361_bib29","doi-asserted-by":"crossref","unstructured":"Steinhilber D (1999) 5-Lipoxygenase: a target for antiinflammatory drugs revisited. Curr Med Chem 6: 71\u201385.","DOI":"10.2174\/0929867306666220207211259"},{"key":"10.1124\/jpet.106.110361_bib30","doi-asserted-by":"crossref","unstructured":"Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, Anderson WF, Zauber A, Hawk E, and Bertagnolli M (2005) Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 352: 1071\u20131080.","DOI":"10.1056\/NEJMoa050405"},{"key":"10.1124\/jpet.106.110361_bib31","doi-asserted-by":"crossref","unstructured":"Spanbroek R, Grabner R, Lotzer K, Hildner M, Urbach A, Ruhling K, Moos MP, Kaiser B, Cohnert TU, Wahlers T, et al. (2003) Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci USA 100: 1238\u20131243.","DOI":"10.1073\/pnas.242716099"},{"key":"10.1124\/jpet.106.110361_bib32","doi-asserted-by":"crossref","unstructured":"Tager AM, Bromley SK, Medoff BD, Islam SA, Bercury SD, Friedrich EB, Carafone AD, Gerszten RE, and Luster AD (2003) Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol 4: 982\u2013990.","DOI":"10.1038\/ni970"},{"key":"10.1124\/jpet.106.110361_bib33","doi-asserted-by":"crossref","unstructured":"Tries S, Laufer S, Radziwon P, and Breddin HK (2002) Antithrombotic and platelet function inhibiting effects of ML3000, a new antiinflammatory drug with Cox\/5-LOX inhibitory activity. Inflamm Res 51: 129\u2013134.","DOI":"10.1007\/PL00000284"},{"key":"10.1124\/jpet.106.110361_bib34","doi-asserted-by":"crossref","unstructured":"Ulbrich H, Soehnlein O, Xie X, Eriksson EE, Lindbom L, Albrecht W, Laufer S, and Dannhardt G (2005) Licofelone, a novel 5-LOX\/COX-inhibitor, attenuates leukocyte rolling and adhesion on endothelium under flow. Biochem Pharmacol 70: 30\u201336.","DOI":"10.1016\/j.bcp.2005.03.031"},{"key":"10.1124\/jpet.106.110361_bib35","doi-asserted-by":"crossref","unstructured":"Vila L (2004) Cyclooxygenase and 5-lipoxygenase pathways in vessel wall: role in atherosclerosis. Med Res Rev 24: 399\u2013424.","DOI":"10.1002\/med.10065"},{"key":"10.1124\/jpet.106.110361_bib36","doi-asserted-by":"crossref","unstructured":"Wang K, Tarakji K, Zhou Z, Zhang M, Forudi F, Zhou X, Koki AT, Smith ME, Keller BT, Topol EJ, et al. (2005) Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model. J Cardiovasc Pharmacol 45: 61\u201367.","DOI":"10.1097\/00005344-200501000-00011"},{"key":"10.1124\/jpet.106.110361_bib37","doi-asserted-by":"crossref","unstructured":"Willerson JT and Ridker PM (2004) Inflammation as a cardiovascular risk factor. Circulation 109: II2\u2013II10.","DOI":"10.1161\/01.CIR.0000129535.04194.38"},{"key":"10.1124\/jpet.106.110361_bib38","doi-asserted-by":"crossref","unstructured":"Zhao L, Moos MP, Grabner R, Pedrono F, Fan J, Kaiser B, John N, Schmidt S, Spanbroek R, Lotzer K, et al. (2004) The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. Nat Med 10: 966\u2013973.","DOI":"10.1038\/nm1099"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524331118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524331118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.106.110361","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:07:01Z","timestamp":1740002821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524331118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0022356524331118"],"URL":"https:\/\/doi.org\/10.1124\/jpet.106.110361","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Licofelone, a Balanced Inhibitor of Cyclooxygenase and 5-Lipoxygenase, Reduces Inflammation in a Rabbit Model of Atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.106.110361","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}